LM Funding America Announces $1.5 Million Share Repurchase Program GlobeNewswire November 03, 2025 TAMPA, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company, today announced that its Board of Directors has authorized a share repurchase program to buy up to […]

Board of Advisors, LLC (BA) Celebrates a Decade of Innovation with Q4 National Summit for High-Growth Entrepreneurs and Investors in Dallas, Nov.3-7 GlobeNewswire November 03, 2025 -2025 is BA's most significant year yet with new locations and an expanding set of programs to facilitate deal flow, high-power networking, and strategic support for company growth- DALLAS,

Kyverna Therapeutics Secures up to $150 Million in Non-Dilutive Financing from Oxford Finance GlobeNewswire November 03, 2025 Initial funding of $25 million from the first of four tranches Facility strengthens Kyverna's financial flexibility, further supporting advancement of its late-stage indications in generalized myasthenia gravis (gMG) and stiff person syndrome (SPS), while also accelerating pre-launch activities

Immutep Receives A$4.6 million R&D Tax Incentive from French Government GlobeNewswire November 03, 2025 Media Release SYDNEY, AUSTRALIA, Nov. 03, 2025 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, is pleased to announce it has received a EUR2,588,954 (~ A$4,567,769 )

Inseego Strengthens Board of Directors with Experienced Operational Leaders in Carrier, AI, and SaaS Nabil Bukhari and Stephen Bye bring decades of experience to Inseego's Board of Directors as it continues to invest to drive growth and profitability GlobeNewswire November 03, 2025 SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Inseego Corp. (Nasdaq: INSG), a

Life Biosciences Appoints Industry Veteran David Guyer, M.D. to Board of Directors Life Bio adds accomplished biotech leader to its Board as the company prepares for an early 2026 initiation of human trials GlobeNewswire November 03, 2025 BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) — Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation therapies

Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025 Data show consistent efficacy, safety, and tolerability findings across multiple clinical trials that evaluated self-administered etripamil GlobeNewswire November 03, 2025 MONTREAL and CHARLOTTE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) — Milestone(R) Pharmaceuticals

Aeries Technology highlights AI-driven execution to accelerate enterprise transformation Consulting-led projects with deep functional specialization have improved velocity, reliability, and operating leverage for mid-market and PE-backed companies GlobeNewswire November 03, 2025 NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (NASDAQ: AERT), a global leader in AI-powered business transformation and Global Capability Center

CERo Therapeutics Announces Listing on OTC Markets GlobeNewswire November 03, 2025 Company's Shares Will Continue to Trade Under Ticker CERO on the OTC Markets SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc. (OTC PINK: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company developing novel T cell therapeutics

AlphaTON Capital Takes Center Stage at TRUST Summit 2025 to Shape the Future of Digital Finance AlphaTON Capital joins forces with cybersecurity leader Hacken at Nasdaq to advance institutional trust and redefine the future of digital asset security GlobeNewswire November 03, 2025 New York, NY, Nov. 03, 2025 (GLOBE NEWSWIRE) — AlphaTON Capital (Nasdaq: ATON)